🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
GSK2118436 is an orally administered, potent and selective small molecule B...
Status
Completed
Location
GSK Investigational Site
Start Date
2012-09-03
Trial ID
NCT01340846
Treatments Being Tested
This is a phase 1 dose-escalation study of nilotinib in combination with fi...
Status
Recruiting
Location
University of Iowa
Start Date
2022-06-01
Trial ID
NCT04903119
The study is being conducted to evaluate the effect of rifampin (a strong C...
Status
Completed
Location
GSK Investigational Site
Start Date
2013-12-20
Trial ID
NCT01954043
Treatments Being Tested
This is an open-label, dose-exploration and expansion study to determine th...
Status
Active Not Recruiting
Location
Mayo Clinic
Start Date
2022-10-31
Trial ID
NCT05585320
The BRAF inhibitors dabrafenib and vemurafenib belong both two a new class ...
Status
Terminated
Location
Department of Dermatology
Start Date
2014-01
Trial ID
NCT02052193
Treatments Being Tested
Colorectal cancer (CRC) is the second leading cause of cancer-related death...
Status
Recruiting
Location
Peking union medical college hospital
Start Date
2026-03-01
Trial ID
NCT07506109
Treatments Being Tested
This prospective, multi-centre, open label, non-randomised phase II trial a...
Status
Unknown
Location
Royal North Shore Hospital
Start Date
2022-07-14
Trial ID
NCT05182931
Treatments Being Tested
MULTISARC is a randomized multicenter study assessing whether high throughp...
Status
Completed
Location
Institut Bergonie
Start Date
2019-10-19
Trial ID
NCT03784014
This was a Phase II, multicenter, non-randomized, open-label study to asses...
Status
Completed
Location
Novartis Investigative Site
Start Date
2011-08-05
Trial ID
NCT01336634
Treatments Being Tested
This is a multicentric prospective non-randomized phase II trial, with two ...
Status
Completed
Location
Gustave Roussy
Start Date
2017-12-27
Trial ID
NCT03244956
Treatments Being Tested